Xiaoxue P. Yin
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
ASPSCR1::TFE3-rearranged renal cell carcinomas: clinicopathologic, molecular, and survival analysis of 30 cases.
Journal: Virchows Archiv : an international journal of pathology
Published: March 12, 2026
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: August 14, 2025
ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 07, 2025
ELOC-mutated Renal Cell Carcinoma: Clinicopathologic, Immunohistochemical, and Molecular Genetic Analysis of 35 Cases.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: July 07, 2025
AI-assisted diagnosis of renal cell carcinoma: educational needs and cognitive assessment based on the WHO classification 2022.
Journal: BMC medical education
Published: April 04, 2025
Fumarate activates the IL-6/JAK/STAT3 pathway by inhibiting KDM4C-mediated H3K36me3 demethylation in FH-knockdown renal cancer cells.
Journal: British journal of cancer
Published: February 11, 2025
Synthesis, characterization, and bioactivity of selenium nanoparticles stabilized by regenerated chitin nanofibers.
Journal: International journal of biological macromolecules
Published: November 28, 2024
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma in Children and Adolescents.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 30, 2024
Patients with ASPSCR1-TFE3 fusion achieve better response to ICI based combination therapy among TFE3-rearranged renal cell carcinoma.
Journal: Molecular cancer
Published: April 21, 2024
Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: Clinicopathological Analysis of 11 Cases
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: April 18, 2024
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.
Journal: Nature communications
Published: March 06, 2024
Benign metastasizing fumarate hydratase (FH)-deficient uterine leiomyomas: clinicopathological and molecular study with first documentation of multi-organ metastases.
Journal: Virchows Archiv : an international journal of pathology
Published: February 04, 2024
Last Updated: 09/26/2026